Adlai Nortye News and Activities

Adlai Nortye is a company listed under the stock ticker ANL (US).

Acquisition, funding and merger involving Adlai Nortye.

• Adlai Nortye has just announced a $150 Million fundraising (posted on April 21 2026).

View the org chart displaying its 13 main executives

Most searched biographies at Adlai Nortye

• Carsten Lu, Chief Executive Officer and Chairman of the Board
• Roger Sawhney, Director
• Lars Birgerson, Director

Create your alert
to follow the executive moves at Adlai Nortye.

Adlai Nortye has 2,428 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (posted on July 15 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Adlai Nortye

• Media
• Media

Social media about Adlai Nortye

• Adlai Nortye on Wikipedia, Google News & Yahoo Finance
• Adlai Nortye on LinkedIn, X (Twitter) & YouTube